Cube Pharmaceuticals: Obtains Drug Registration Certificate for Azilsartan Medoxomil Potassium Tablets
Lifang Pharmaceutical has received approval from China's National Medical Products Administration for its Azilsartan Medoxomil Potassium tablets, indicated for treating adult primary hypertension. This marks a significant step for the company in the pharmaceutical sector. The approval covers both 40mg and 80mg dosages of the medication. AI